70
Exosomes_AD, RA
Fraunhofer IZI
Cell therapy
Immunology, CNS disease
Target Identification or Validation
• The Fraunhofer researchers developed EVs to design new targeted
therapies for a wide variety of diseases
• They are specialized at customizing and testing MSC-EVs. These findings could open a new way for novel cell-free therapeutics to prevent CNS chronic inflammation
• We are looking for industry partners interested in testing new EV
technologies